Alfuzosin Hydrochloride
Product Images NDC 0440-5000

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Alfuzosin Hydrochloride (NDC 0440-5000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Liberty Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dia1 (Alfuzosin Tablet 1)

FDA Label Image

Alf4 (Alfuzosin Tablet 2)

FDA Label Image

Dia6 (Alfuzosin Tablet 3)

FDA Label Image

Dia7 (Alfuzosin Tablet 4)

FDA Label Image

Dia8 (Alfuzosin Tablet 5)

FDA Label Image

Dia9 (Alfuzosin Tablet 6)

FDA Label Image

Dia10 (Alfuzosin Tablet 7)

FDA Label Image

Dia11 (Alfuzosin Tablet 8)

This appears to be a comparison of two groups (Placebo and Alfuzosin HCl) with 150 and 151 individuals, respectively. The data may be related to a 28-day treatment and the statistical significance of the results (p>0.08) is provided. No further information is available from the given text.*

FDA Label Image

Image (Alfuzosin Tablet 9)

This is a description of a prescription medicine that is sold only for US government medical facilities. This medicine is a generic version of the brand-name drug Uroxatral and contains 10 mg of Alfuzosin ER. The drug is manufactured by Invagen Pharmaceuticals Inc. and packaged by Aidarex Pharmaceuticals LLC. The product is in tablet form, with a quantity of 90 tablets per package, and is controlled in a temperature of 25 degrees Celsius. The product label indicates the lot number, expiration date, and dosing requirements.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.